Last Updated : January 15, 2024
Details
FilesGeneric Name:
everolimus
Project Status:
Active
Therapeutic Area:
Tuberous Sclerosis Complex (TSC)
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0836-000
Call for patient/clinician input closed:
Biosimilar:
No
Fee Schedule:
Pending
Indications:
Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC).
Call for patient input open | 14-Dec-23 |
---|---|
Call for patient/clinician input open | 14-Dec-23 |
Call for patient input closed | 12-Feb-24 |
Call for patient/clinician input closed | 12-Feb-24 |
Call for industry input open | 14-Dec-23 |
Call for industry input closed | 12-Feb-24 |
Submission received | 12-Dec-23 |
Files
Last Updated : January 15, 2024